TENM3-AS1

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, TENM3-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TENM3-AS1 data layer compared with 24 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher TENM3-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated TENM3-AS1 expression acts as an unfavorable survival marker.

COAD and LIHC are the cancer types where TENM3-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
COADOSMedianIII,IV0.1420.792<.00120view →
LIHCDFSMedianAll0.0930.544.00118view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TENM3-AS1–COAD (OS)

Kaplan–Meier survival curve for TENM3-AS1 mutant vs wild-type samples in COAD.

Open the COAD breakdown →

Exploration